Skip to content

Clinical trials

Completed Multiple Myeloma trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Completed Country / region: Switzerland Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20052
20081
20103
20115
20124
20131
20142
20151
20162
20171
20181
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene6
Insel Gruppe AG, University Hospital Bern4
Bristol-Myers Squibb3
European Organisation for Research and Treatment of Cancer - EORTC3
Amgen2
Takeda2
Cantonal Hospital of St. Gallen1
Celgene Corporation1
GlaxoSmithKline1
Mundipharma Research Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma29
Neoplasms, Plasma Cell7
Recurrence6
Hodgkin Disease5
Lymphoma, T-Cell, Cutaneous5
Leukemia, Myeloid, Acute4
Lymphoma, Follicular4
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Mantle-Cell4
Neoplasms4

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.